Alcohol misuse is focused on binge and heavy drinking patterns within a community or at the population level. This guide will serve as a compendium of key policies for the prevention of alcohol misuse that have been identified as evidence-based by robust scientific literature.

A guide for community leaders to use when planning events on underage drinking and substance use prevention for parents and caregivers, educators, and other adult role models. The guide offers best practices and sample materials for planning successful events.

A guide for community leaders to use when working with the media to promote underage drinking and substance use prevention resources for parents and caregivers, educators, and other adult role models. The guide offers best practices and sample materials for engaging the media.

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

This guide highlights steps taken by the Frostburg State University community to reduce underage and high-risk drinking among the student population and discusses how these strategies were implemented.

This guide shows how HBCUs, as well as other institutions that primarily serve students from a distinct background, region, or culture, can create prevention strategies to meet the unique needs of those students.

This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.

This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.